<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR201007</article-id>
      <title-group>
        <article-title>Synthesis and Anti-Inflammatory Activity of a Novel Series of new BenzoxazoleDerivatives</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>Kankanala Naveen</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KondaSwathi</surname>
            <given-names>KondaSwathi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Minugonda</surname>
            <given-names>Bindhu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MandaSarangapani</surname>
            <given-names>MandaSarangapani</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2014-01-01">
        <month>01</month>
        <day>01</day>
        <year>2014</year>
      </pub-date>
      <volume>2</volume>
      <issue>1</issue>
      <abstract>
        <p>In the present investigation we have synthesized a series of new 2-arylidene-N-(benzoxazole-2-yl) hydrazine carboxamide and 2-arylidene-N-(5-chloro benzoxazole-2-yl) hydrazine carboxamide derivatives (VIIIa-VIIIf&amp; VIIIA-VIIIE). The newly synthesized derivatives were characterized by using the data of IR, &apos;H NMR and Mass Spectral analysis. Thus synthesized and characterized targeted compounds were further screened for their anti-inflammatory activity by using Carrageenan - induced paw edema rat model. Among all the newly synthesized derivatives, Compounds VIIIa-c and Compounds VIIIA-C were reduced the inflammation very significantly , thus these compounds showed promising anti-inflammatory activity and compounds VIIId-VIIIf&amp; VIIID-VIIIF showed moderate anti-inflammatory activity.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>benzoxazoles</kwd>
        <kwd>IR</kwd>
        <kwd>&apos; HNMR</kwd>
        <kwd>Mass Spectroscopy and anti-inflammatory activity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
